CClinicalTrials.gg
CompletedNCT05201339Updated Oct 3, 2024

Effect of Head-neck Rotation on I-gel™ Insertion

An interventional study of Standard method and Hean and Neck Rotation in Supraglottic Airway Device, Intubation; Difficult or Failed and Airway Complication of Anesthesia, sponsored by Seoul National University Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2024-10-03.

Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
172
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Study summary

According to previous studies, head and neck rotation reduces the tongue from being rolled back by gravity, which resulted in increasing patency of the upper airway. Therefore, the purpose of this study is to verify whether head and neck rotation increases the first attempt success rate of i-gel™.

Read the detailed description

I-gel™ insertion has been reported that the success rate of insertion on the first attempt is 78.5%. There may be several causes of insertion failure. Tongue folding is a major obstacle preventing appropriate i-gel™ placement. To solve this problem, the previous study has proven the efficacy of the rotational technical for I-gel™ insertion and reported a success rate of 97%.

However, the rotation of i-gel™ in the oral cavity may be limited, and it may take some learning curve to get used to it. According to previous studies, head and neck rotation increases the cross-sectional area of the upper airway, which resulted in increasing patency of the upper airway. Therefore, the purpose of this study is to verify whether head and neck rotation increases the first attempt success rate of i-gel™.

02

Conditions studied

  • Supraglottic Airway Device
  • Intubation; Difficult or Failed
  • Airway Complication of Anesthesia

Keywords

  • Supraglottic airway device
  • Intubation
  • Airway
03

In context

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,860 studies on the registry; 275 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ASA Physical Status Classification Grade 1-3
  • Patients who can provide written consent to participate in clinical trials
  • Patients requiring the I-gel™ during surgery

Exclusion criteria

Exclusion Criteria:

  • Outpatient surgery
  • Patients who have the neurologic disease or cognitive impairment
  • Patients who take antipsychotic drugs
  • Body mass index > 35 kg/m2
  • Mouth opening \< 2.5 cm
  • Limited neck extension or cervical mobilization (Ex: Atlanto-axial subluxation, History of cervical spine surgery or head and neck surgery)
  • Those with a recent sore throat
  • Those with weak dentation
  • Patients at risk of aspiration (Ex: Pregnancy, Gastroesophageal reflux disease or hiatus hernia)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
172 participants (actual)

Study arms

  • Active comparator
    Standard method

    Insert I-gel™ according to the manufacturer's instruction. Take the sniffing position and gently move the i-gel™ along the hard palate to the soft palate and the posterior oropharynx.

    Procedure: Standard method

  • Experimental
    Head-neck rotation

    After rotating the patient's head and neck to the left maximally, insert the i-gel™ from the right side of the tongue to the midline. When the tip reaches the soft palate and oropharynx positions, turn the head and neck back to the neutral position.

    Procedure: Hean and Neck Rotation

Interventions

  • ProcedureStandard method

    Insert I-gel™ according to the manufacturer's instruction. Take the sniffing position and gently move the i-gel™ along the hard palate to the soft palate and the posterior oropharynx.

  • ProcedureHean and Neck Rotation

    After rotating the patient's head and neck to the left maximally, insert the i-gel™ from the right side of the tongue to the midline. When the tip reaches the soft palate and oropharynx positions, turn the head and neck back to the neutral position.

06

What researchers measure

Primary outcomes

  1. First attempt success rate

    After the first attempt on insertion of i-gel™ without withdrawal or redirection, the effectiveness of the airway is judged based on a square-wave capnograph and no audible leak with peak airway pressures ≥ 10 cmH2O during manual ventilation.

    Time frame: Induction of anesthesia during intraoperative period

Secondary outcomes

  1. Second attempt success rate

    After the second attempt on insertion of i-gel™, the effectiveness of the airway is judged based on a square-wave capnograph and no audible leak with peak airway pressures ≥ 10 cmH2O during manual ventilation.

    Time frame: Induction of anesthesia during intraoperative period

  2. Insertion time for successful insertion; s

    Time from insertion of i-gel™ into the oral cavity until appropriate placement.

    Time frame: Induction of anesthesia during intraoperative period

  3. Time required for successful insertion; s

    Time insertion of i-gel™ into the oral cavity until After the first attempt on insertion of i-gel™ without withdrawal or redirection, the effectiveness of the airway is judged based on a square-wave capnograph and no audible leak with peak airway pressures ≥ 10 cmH2O during manual ventilation.

    Time frame: Induction of anesthesia during intraoperative period

  4. Third attempt

    If the attempt of assigned method fails twice, then try third attempt.

    Time frame: Induction of anesthesia during intraoperative period

  5. Third attempt success rate

    If the attempt of assigned method fails, but the third attempt is successful with another method.

    Time frame: Induction of anesthesia during intraoperative period

  6. Manipulations required rate

    An assistant assists when all attempt fail.

    Time frame: Induction of anesthesia during intraoperative period

  7. Change to intubation

    Conversion rate from insertion of i-gel™ to tracheal intubation.

    Time frame: Induction of anesthesia during intraoperative period

  8. Blood staining after extubation

    Blood stating to evaluate the postoperative complication and outcome in patients received each intubation method during surgery

    Time frame: Induction of anesthesia during intraoperative period

  9. Sore throat after extubation

    Sore throat to evaluate the postoperative complication and outcome in patients received each intubation method during surgery

    Time frame: Extubation during intraoperative period

  10. Hoarseness after extubation

    Hoarseness to evaluate the postoperative complication and outcome in patients received each intubation method during surgery

    Time frame: Extubation during intraoperative period

  11. Sore throat at 24 hours after surgery

    Sore throat to evaluate the postoperative complication and outcome in patients received each intubation method during surgery

    Time frame: 24 hours after surgery (up to 24hours)

  12. Hoarseness at 24 hours after surgery

    Hoarseness to evaluate the postoperative complication and outcome in patients received each intubation method during surgery

    Time frame: 24 hours after surgery (up to 24hours)

07

Study locations

1 site
  • Seoul National University Hospital
    Seoul, 03080, Korea, Republic of
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05201339
Lead sponsor
Seoul National University Hospital
Responsible party
Karam Nam, MD (Seoul National University Hospital, Seoul National University Hospital) — Principal investigator
First posted
Jan 21, 2022
Start date
Feb 25, 2022
Primary completion
Jun 2, 2023
Completion
Jun 2, 2023
Last update
Oct 3, 2024

Study contacts

Karam Nam, MD
study director · Seoul National University Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion